Global Biosimilar Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Drug market.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
Key Features:
The report on Biosimilar Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Drug market. It may include historical data, market segmentation by Type (e.g., Injection, Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Drug industry. This include advancements in Biosimilar Drug technology, Biosimilar Drug new entrants, Biosimilar Drug new investment, and other innovations that are shaping the future of Biosimilar Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Drug market.
Market Segmentation:
Biosimilar Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Biosimilar Drug market?
What factors are driving Biosimilar Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilar Drug market opportunities vary by end market size?
How does Biosimilar Drug break out type, application?
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Drug market.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
Key Features:
The report on Biosimilar Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Drug market. It may include historical data, market segmentation by Type (e.g., Injection, Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Drug industry. This include advancements in Biosimilar Drug technology, Biosimilar Drug new entrants, Biosimilar Drug new investment, and other innovations that are shaping the future of Biosimilar Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Drug market.
Market Segmentation:
Biosimilar Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Injection
- Tablets
- Other Types
- Ankylosing Spondylitis
- Tumor
- Rheumatoid Arthrtis
- Cardiovascular
- Other Application
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CP Guojian Pharma
- Biotech Pharma
- Celgen Pharma
- Henlius
- Amgen
- Eli Lilly
- Sandoz
- Changchun High Tech
- Innovent
What is the 10-year outlook for the global Biosimilar Drug market?
What factors are driving Biosimilar Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biosimilar Drug market opportunities vary by end market size?
How does Biosimilar Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Biosimilar Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Biosimilar Drug by Country/Region, 2019, 2023 & 2030
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Biosimilar Drug Sale Price by Type (2019-2024)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Biosimilar Drug Sale Price by Application (2019-2024)
3 GLOBAL BIOSIMILAR DRUG BY COMPANY
3.1 Global Biosimilar Drug Breakdown Data by Company
3.1.1 Global Biosimilar Drug Annual Sales by Company (2019-2024)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2019-2024)
3.2 Global Biosimilar Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Biosimilar Drug Revenue by Company (2019-2024)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2019-2024)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Key Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Biosimilar Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Biosimilar Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Biosimilar Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Biosimilar Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Biosimilar Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Biosimilar Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biosimilar Drug Sales Growth
4.4 APAC Biosimilar Drug Sales Growth
4.5 Europe Biosimilar Drug Sales Growth
4.6 Middle East & Africa Biosimilar Drug Sales Growth
5 AMERICAS
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2019-2024)
5.1.2 Americas Biosimilar Drug Revenue by Country (2019-2024)
5.2 Americas Biosimilar Drug Sales by Type
5.3 Americas Biosimilar Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2019-2024)
6.1.2 APAC Biosimilar Drug Revenue by Region (2019-2024)
6.2 APAC Biosimilar Drug Sales by Type
6.3 APAC Biosimilar Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2019-2024)
7.1.2 Europe Biosimilar Drug Revenue by Country (2019-2024)
7.2 Europe Biosimilar Drug Sales by Type
7.3 Europe Biosimilar Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Biosimilar Drug Sales by Type
8.3 Middle East & Africa Biosimilar Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug
10.4 Industry Chain Structure of Biosimilar Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilar Drug Distributors
11.3 Biosimilar Drug Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
12.1 Global Biosimilar Drug Market Size Forecast by Region
12.1.1 Global Biosimilar Drug Forecast by Region (2025-2030)
12.1.2 Global Biosimilar Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilar Drug Forecast by Type
12.7 Global Biosimilar Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CP Guojian Pharma
13.1.1 CP Guojian Pharma Company Information
13.1.2 CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
13.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CP Guojian Pharma Main Business Overview
13.1.5 CP Guojian Pharma Latest Developments
13.2 Biotech Pharma
13.2.1 Biotech Pharma Company Information
13.2.2 Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
13.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biotech Pharma Main Business Overview
13.2.5 Biotech Pharma Latest Developments
13.3 Celgen Pharma
13.3.1 Celgen Pharma Company Information
13.3.2 Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
13.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Celgen Pharma Main Business Overview
13.3.5 Celgen Pharma Latest Developments
13.4 Henlius
13.4.1 Henlius Company Information
13.4.2 Henlius Biosimilar Drug Product Portfolios and Specifications
13.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Henlius Main Business Overview
13.4.5 Henlius Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biosimilar Drug Product Portfolios and Specifications
13.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biosimilar Drug Product Portfolios and Specifications
13.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Biosimilar Drug Product Portfolios and Specifications
13.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Changchun High Tech
13.8.1 Changchun High Tech Company Information
13.8.2 Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
13.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Changchun High Tech Main Business Overview
13.8.5 Changchun High Tech Latest Developments
13.9 Innovent
13.9.1 Innovent Company Information
13.9.2 Innovent Biosimilar Drug Product Portfolios and Specifications
13.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Innovent Main Business Overview
13.9.5 Innovent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Biosimilar Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Biosimilar Drug by Country/Region, 2019, 2023 & 2030
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Biosimilar Drug Sale Price by Type (2019-2024)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Biosimilar Drug Sale Price by Application (2019-2024)
3 GLOBAL BIOSIMILAR DRUG BY COMPANY
3.1 Global Biosimilar Drug Breakdown Data by Company
3.1.1 Global Biosimilar Drug Annual Sales by Company (2019-2024)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2019-2024)
3.2 Global Biosimilar Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Biosimilar Drug Revenue by Company (2019-2024)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2019-2024)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Key Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
4.1 World Historic Biosimilar Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Biosimilar Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Biosimilar Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Biosimilar Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Biosimilar Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Biosimilar Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biosimilar Drug Sales Growth
4.4 APAC Biosimilar Drug Sales Growth
4.5 Europe Biosimilar Drug Sales Growth
4.6 Middle East & Africa Biosimilar Drug Sales Growth
5 AMERICAS
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2019-2024)
5.1.2 Americas Biosimilar Drug Revenue by Country (2019-2024)
5.2 Americas Biosimilar Drug Sales by Type
5.3 Americas Biosimilar Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2019-2024)
6.1.2 APAC Biosimilar Drug Revenue by Region (2019-2024)
6.2 APAC Biosimilar Drug Sales by Type
6.3 APAC Biosimilar Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2019-2024)
7.1.2 Europe Biosimilar Drug Revenue by Country (2019-2024)
7.2 Europe Biosimilar Drug Sales by Type
7.3 Europe Biosimilar Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Biosimilar Drug Sales by Type
8.3 Middle East & Africa Biosimilar Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug
10.4 Industry Chain Structure of Biosimilar Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilar Drug Distributors
11.3 Biosimilar Drug Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILAR DRUG BY GEOGRAPHIC REGION
12.1 Global Biosimilar Drug Market Size Forecast by Region
12.1.1 Global Biosimilar Drug Forecast by Region (2025-2030)
12.1.2 Global Biosimilar Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilar Drug Forecast by Type
12.7 Global Biosimilar Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CP Guojian Pharma
13.1.1 CP Guojian Pharma Company Information
13.1.2 CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
13.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CP Guojian Pharma Main Business Overview
13.1.5 CP Guojian Pharma Latest Developments
13.2 Biotech Pharma
13.2.1 Biotech Pharma Company Information
13.2.2 Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
13.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biotech Pharma Main Business Overview
13.2.5 Biotech Pharma Latest Developments
13.3 Celgen Pharma
13.3.1 Celgen Pharma Company Information
13.3.2 Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
13.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Celgen Pharma Main Business Overview
13.3.5 Celgen Pharma Latest Developments
13.4 Henlius
13.4.1 Henlius Company Information
13.4.2 Henlius Biosimilar Drug Product Portfolios and Specifications
13.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Henlius Main Business Overview
13.4.5 Henlius Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biosimilar Drug Product Portfolios and Specifications
13.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biosimilar Drug Product Portfolios and Specifications
13.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Biosimilar Drug Product Portfolios and Specifications
13.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Changchun High Tech
13.8.1 Changchun High Tech Company Information
13.8.2 Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
13.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Changchun High Tech Main Business Overview
13.8.5 Changchun High Tech Latest Developments
13.9 Innovent
13.9.1 Innovent Company Information
13.9.2 Innovent Biosimilar Drug Product Portfolios and Specifications
13.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Innovent Main Business Overview
13.9.5 Innovent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilar Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Biosimilar Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Major Players of Other Types
Table 6. Global Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 7. Global Biosimilar Drug Sales Market Share by Type (2019-2024)
Table 8. Global Biosimilar Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Biosimilar Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Biosimilar Drug Sale Price by Type (2019-2024) & (USD/Dose)
Table 11. Global Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 12. Global Biosimilar Drug Sales Market Share by Application (2019-2024)
Table 13. Global Biosimilar Drug Revenue by Application (2019-2024)
Table 14. Global Biosimilar Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Biosimilar Drug Sale Price by Application (2019-2024) & (USD/Dose)
Table 16. Global Biosimilar Drug Sales by Company (2019-2024) & (K Dose)
Table 17. Global Biosimilar Drug Sales Market Share by Company (2019-2024)
Table 18. Global Biosimilar Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Biosimilar Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Biosimilar Drug Sale Price by Company (2019-2024) & (USD/Dose)
Table 21. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 22. Players Biosimilar Drug Products Offered
Table 23. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Biosimilar Drug Sales by Geographic Region (2019-2024) & (K Dose)
Table 27. Global Biosimilar Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Biosimilar Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Biosimilar Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Biosimilar Drug Sales by Country/Region (2019-2024) & (K Dose)
Table 31. Global Biosimilar Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Biosimilar Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Biosimilar Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 35. Americas Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 39. Americas Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 40. APAC Biosimilar Drug Sales by Region (2019-2024) & (K Dose)
Table 41. APAC Biosimilar Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Biosimilar Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Biosimilar Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 45. APAC Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 46. Europe Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 47. Europe Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 51. Europe Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 52. Middle East & Africa Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 53. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 57. Middle East & Africa Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 58. Key Market Drivers & Growth Opportunities of Biosimilar Drug
Table 59. Key Market Challenges & Risks of Biosimilar Drug
Table 60. Key Industry Trends of Biosimilar Drug
Table 61. Biosimilar Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Biosimilar Drug Distributors List
Table 64. Biosimilar Drug Customer List
Table 65. Global Biosimilar Drug Sales Forecast by Region (2025-2030) & (K Dose)
Table 66. Global Biosimilar Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 68. Americas Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Biosimilar Drug Sales Forecast by Region (2025-2030) & (K Dose)
Table 70. APAC Biosimilar Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 72. Europe Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 74. Middle East & Africa Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Biosimilar Drug Sales Forecast by Type (2025-2030) & (K Dose)
Table 76. Global Biosimilar Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Biosimilar Drug Sales Forecast by Application (2025-2030) & (K Dose)
Table 78. Global Biosimilar Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
Table 81. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. CP Guojian Pharma Main Business
Table 83. CP Guojian Pharma Latest Developments
Table 84. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
Table 86. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. Biotech Pharma Main Business
Table 88. Biotech Pharma Latest Developments
Table 89. Celgen Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
Table 91. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. Celgen Pharma Main Business
Table 93. Celgen Pharma Latest Developments
Table 94. Henlius Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Henlius Biosimilar Drug Product Portfolios and Specifications
Table 96. Henlius Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Henlius Main Business
Table 98. Henlius Latest Developments
Table 99. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Biosimilar Drug Product Portfolios and Specifications
Table 101. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. Amgen Main Business
Table 103. Amgen Latest Developments
Table 104. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly Biosimilar Drug Product Portfolios and Specifications
Table 106. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Sandoz Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Sandoz Biosimilar Drug Product Portfolios and Specifications
Table 111. Sandoz Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 112. Sandoz Main Business
Table 113. Sandoz Latest Developments
Table 114. Changchun High Tech Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
Table 116. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 117. Changchun High Tech Main Business
Table 118. Changchun High Tech Latest Developments
Table 119. Innovent Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Innovent Biosimilar Drug Product Portfolios and Specifications
Table 121. Innovent Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 122. Innovent Main Business
Table 123. Innovent Latest Developments
Table 1. Biosimilar Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Biosimilar Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Major Players of Other Types
Table 6. Global Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 7. Global Biosimilar Drug Sales Market Share by Type (2019-2024)
Table 8. Global Biosimilar Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Biosimilar Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Biosimilar Drug Sale Price by Type (2019-2024) & (USD/Dose)
Table 11. Global Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 12. Global Biosimilar Drug Sales Market Share by Application (2019-2024)
Table 13. Global Biosimilar Drug Revenue by Application (2019-2024)
Table 14. Global Biosimilar Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Biosimilar Drug Sale Price by Application (2019-2024) & (USD/Dose)
Table 16. Global Biosimilar Drug Sales by Company (2019-2024) & (K Dose)
Table 17. Global Biosimilar Drug Sales Market Share by Company (2019-2024)
Table 18. Global Biosimilar Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Biosimilar Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Biosimilar Drug Sale Price by Company (2019-2024) & (USD/Dose)
Table 21. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 22. Players Biosimilar Drug Products Offered
Table 23. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Biosimilar Drug Sales by Geographic Region (2019-2024) & (K Dose)
Table 27. Global Biosimilar Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Biosimilar Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Biosimilar Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Biosimilar Drug Sales by Country/Region (2019-2024) & (K Dose)
Table 31. Global Biosimilar Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Biosimilar Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Biosimilar Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 35. Americas Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 39. Americas Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 40. APAC Biosimilar Drug Sales by Region (2019-2024) & (K Dose)
Table 41. APAC Biosimilar Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Biosimilar Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Biosimilar Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 45. APAC Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 46. Europe Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 47. Europe Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 51. Europe Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 52. Middle East & Africa Biosimilar Drug Sales by Country (2019-2024) & (K Dose)
Table 53. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Biosimilar Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Biosimilar Drug Sales by Type (2019-2024) & (K Dose)
Table 57. Middle East & Africa Biosimilar Drug Sales by Application (2019-2024) & (K Dose)
Table 58. Key Market Drivers & Growth Opportunities of Biosimilar Drug
Table 59. Key Market Challenges & Risks of Biosimilar Drug
Table 60. Key Industry Trends of Biosimilar Drug
Table 61. Biosimilar Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Biosimilar Drug Distributors List
Table 64. Biosimilar Drug Customer List
Table 65. Global Biosimilar Drug Sales Forecast by Region (2025-2030) & (K Dose)
Table 66. Global Biosimilar Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 68. Americas Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Biosimilar Drug Sales Forecast by Region (2025-2030) & (K Dose)
Table 70. APAC Biosimilar Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 72. Europe Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Biosimilar Drug Sales Forecast by Country (2025-2030) & (K Dose)
Table 74. Middle East & Africa Biosimilar Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Biosimilar Drug Sales Forecast by Type (2025-2030) & (K Dose)
Table 76. Global Biosimilar Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Biosimilar Drug Sales Forecast by Application (2025-2030) & (K Dose)
Table 78. Global Biosimilar Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. CP Guojian Pharma Biosimilar Drug Product Portfolios and Specifications
Table 81. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. CP Guojian Pharma Main Business
Table 83. CP Guojian Pharma Latest Developments
Table 84. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Biotech Pharma Biosimilar Drug Product Portfolios and Specifications
Table 86. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. Biotech Pharma Main Business
Table 88. Biotech Pharma Latest Developments
Table 89. Celgen Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Celgen Pharma Biosimilar Drug Product Portfolios and Specifications
Table 91. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. Celgen Pharma Main Business
Table 93. Celgen Pharma Latest Developments
Table 94. Henlius Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Henlius Biosimilar Drug Product Portfolios and Specifications
Table 96. Henlius Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Henlius Main Business
Table 98. Henlius Latest Developments
Table 99. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Biosimilar Drug Product Portfolios and Specifications
Table 101. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. Amgen Main Business
Table 103. Amgen Latest Developments
Table 104. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly Biosimilar Drug Product Portfolios and Specifications
Table 106. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Sandoz Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Sandoz Biosimilar Drug Product Portfolios and Specifications
Table 111. Sandoz Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 112. Sandoz Main Business
Table 113. Sandoz Latest Developments
Table 114. Changchun High Tech Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Changchun High Tech Biosimilar Drug Product Portfolios and Specifications
Table 116. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 117. Changchun High Tech Main Business
Table 118. Changchun High Tech Latest Developments
Table 119. Innovent Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Innovent Biosimilar Drug Product Portfolios and Specifications
Table 121. Innovent Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 122. Innovent Main Business
Table 123. Innovent Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Biosimilar Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Other Types
Figure 12. Global Biosimilar Drug Sales Market Share by Type in 2023
Figure 13. Global Biosimilar Drug Revenue Market Share by Type (2019-2024)
Figure 14. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 15. Global Biosimilar Drug Market: Ankylosing Spondylitis (2019-2024) & (K Dose)
Figure 16. Biosimilar Drug Consumed in Tumor
Figure 17. Global Biosimilar Drug Market: Tumor (2019-2024) & (K Dose)
Figure 18. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2019-2024) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Cardiovascular
Figure 21. Global Biosimilar Drug Market: Cardiovascular (2019-2024) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Other Application
Figure 23. Global Biosimilar Drug Market: Other Application (2019-2024) & (K Dose)
Figure 24. Global Biosimilar Drug Sales Market Share by Application (2023)
Figure 25. Global Biosimilar Drug Revenue Market Share by Application in 2023
Figure 26. Biosimilar Drug Sales Market by Company in 2023 (K Dose)
Figure 27. Global Biosimilar Drug Sales Market Share by Company in 2023
Figure 28. Biosimilar Drug Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Biosimilar Drug Revenue Market Share by Company in 2023
Figure 30. Global Biosimilar Drug Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Biosimilar Drug Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 33. Americas Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 34. APAC Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 35. APAC Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 36. Europe Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 37. Europe Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 39. Middle East & Africa Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 40. Americas Biosimilar Drug Sales Market Share by Country in 2023
Figure 41. Americas Biosimilar Drug Revenue Market Share by Country in 2023
Figure 42. Americas Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 43. Americas Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 44. United States Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Biosimilar Drug Sales Market Share by Region in 2023
Figure 49. APAC Biosimilar Drug Revenue Market Share by Regions in 2023
Figure 50. APAC Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 51. APAC Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 52. China Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Biosimilar Drug Sales Market Share by Country in 2023
Figure 60. Europe Biosimilar Drug Revenue Market Share by Country in 2023
Figure 61. Europe Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 62. Europe Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 63. Germany Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Biosimilar Drug Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Biosimilar Drug Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 72. Egypt Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2023
Figure 78. Manufacturing Process Analysis of Biosimilar Drug
Figure 79. Industry Chain Structure of Biosimilar Drug
Figure 80. Channels of Distribution
Figure 81. Global Biosimilar Drug Sales Market Forecast by Region (2025-2030)
Figure 82. Global Biosimilar Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Biosimilar Drug Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Biosimilar Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Biosimilar Drug Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Biosimilar Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Biosimilar Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Other Types
Figure 12. Global Biosimilar Drug Sales Market Share by Type in 2023
Figure 13. Global Biosimilar Drug Revenue Market Share by Type (2019-2024)
Figure 14. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 15. Global Biosimilar Drug Market: Ankylosing Spondylitis (2019-2024) & (K Dose)
Figure 16. Biosimilar Drug Consumed in Tumor
Figure 17. Global Biosimilar Drug Market: Tumor (2019-2024) & (K Dose)
Figure 18. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2019-2024) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Cardiovascular
Figure 21. Global Biosimilar Drug Market: Cardiovascular (2019-2024) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Other Application
Figure 23. Global Biosimilar Drug Market: Other Application (2019-2024) & (K Dose)
Figure 24. Global Biosimilar Drug Sales Market Share by Application (2023)
Figure 25. Global Biosimilar Drug Revenue Market Share by Application in 2023
Figure 26. Biosimilar Drug Sales Market by Company in 2023 (K Dose)
Figure 27. Global Biosimilar Drug Sales Market Share by Company in 2023
Figure 28. Biosimilar Drug Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Biosimilar Drug Revenue Market Share by Company in 2023
Figure 30. Global Biosimilar Drug Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Biosimilar Drug Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 33. Americas Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 34. APAC Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 35. APAC Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 36. Europe Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 37. Europe Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Biosimilar Drug Sales 2019-2024 (K Dose)
Figure 39. Middle East & Africa Biosimilar Drug Revenue 2019-2024 ($ Millions)
Figure 40. Americas Biosimilar Drug Sales Market Share by Country in 2023
Figure 41. Americas Biosimilar Drug Revenue Market Share by Country in 2023
Figure 42. Americas Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 43. Americas Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 44. United States Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Biosimilar Drug Sales Market Share by Region in 2023
Figure 49. APAC Biosimilar Drug Revenue Market Share by Regions in 2023
Figure 50. APAC Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 51. APAC Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 52. China Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Biosimilar Drug Sales Market Share by Country in 2023
Figure 60. Europe Biosimilar Drug Revenue Market Share by Country in 2023
Figure 61. Europe Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 62. Europe Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 63. Germany Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Biosimilar Drug Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Biosimilar Drug Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2019-2024)
Figure 72. Egypt Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Biosimilar Drug Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2023
Figure 78. Manufacturing Process Analysis of Biosimilar Drug
Figure 79. Industry Chain Structure of Biosimilar Drug
Figure 80. Channels of Distribution
Figure 81. Global Biosimilar Drug Sales Market Forecast by Region (2025-2030)
Figure 82. Global Biosimilar Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Biosimilar Drug Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Biosimilar Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Biosimilar Drug Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Biosimilar Drug Revenue Market Share Forecast by Application (2025-2030)
